Press Releases Filter By Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 January 7, 2019 Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate December 21, 2018 Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate December 17, 2018 Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate December 6, 2018 Valneva and HOOKIPA Sign a Collaboration and Manufacturing Agreement December 4, 2018 Valneva to Conduct Investor and Partnering Meetings During the 37 th Annual J.P. Morgan Healthcare Conference November 19, 2018 Emergent Biosolutions and Valneva Report Positive Phase 1 Results for Their Vaccine Candidate Against the Zika Virus November 8, 2018 Valneva Reports Nine Month Results for 2018, Confirms Guidance, Strengthens Balance Sheet with €50m Financing October 25, 2018 Valneva Receives Positive Feedback from EMA on its further Development for Lyme Disease Vaccine VLA15 October 16, 2018 Valneva Announces Progress of Chikungunya Vaccine Candidate October 5, 2018 Valneva Announces FDA Approval of Accelerated IXIARO® Vaccination Schedule 1 2 3 4 5 … 28
January 7, 2019 Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate
December 17, 2018 Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate
December 4, 2018 Valneva to Conduct Investor and Partnering Meetings During the 37 th Annual J.P. Morgan Healthcare Conference
November 19, 2018 Emergent Biosolutions and Valneva Report Positive Phase 1 Results for Their Vaccine Candidate Against the Zika Virus
November 8, 2018 Valneva Reports Nine Month Results for 2018, Confirms Guidance, Strengthens Balance Sheet with €50m Financing
October 25, 2018 Valneva Receives Positive Feedback from EMA on its further Development for Lyme Disease Vaccine VLA15
